{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:53:58Z","timestamp":1774972438918,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1038\/nrc1434","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T12:36:00Z","timestamp":1094042160000},"page":"718-727","source":"Crossref","is-referenced-by-count":148,"title":["Switching on kinases: oncogenic activation of BRAF and the PDGFR family"],"prefix":"10.1038","volume":"4","author":[{"given":"Nick J.","family":"Dibb","sequence":"first","affiliation":[]},{"given":"Stephen M.","family":"Dilworth","sequence":"additional","affiliation":[]},{"given":"Clifford D.","family":"Mol","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnrc1434_CR1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/417906a","volume":"417","author":"PM Pollock","year":"2002","unstructured":"Pollock, P. M. & Meltzer, P. S. Lucky draw in the gene raffle Nature 417, 906\u2013907 (2002).","journal-title":"Nature"},{"key":"BFnrc1434_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949\u2013954 (2002).","journal-title":"Nature"},{"key":"BFnrc1434_CR3","first-page":"25","volume":"1653","author":"KE Mercer","year":"2003","unstructured":"Mercer, K. E. & Pritchard, C. A. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta 1653, 25\u201350 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrc1434_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-1119(03)00816-3","volume":"320","author":"SH Yang","year":"2003","unstructured":"Yang, S. H., Sharrocks, A. D. & Whitmarsh, A. J. Transcriptional regulation by the MAP kinase signalling cascades. Gene 320, 3\u201321 (2003).","journal-title":"Gene"},{"key":"BFnrc1434_CR5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ng1054","volume":"33","author":"PM Pollock","year":"2003","unstructured":"Pollock, P. M. et al. High frequency of BRAF mutations in nevi. Nature Genet. 33, 595\u2013602 (2003).","journal-title":"Nature Genet."},{"key":"BFnrc1434_CR6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PTC Wan","year":"2004","unstructured":"Wan, P. T. C. et al. Mechanism of activation of the RAF\u2013ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855\u2013867 (2004).","journal-title":"Cell"},{"key":"BFnrc1434_CR7","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","volume":"92","author":"T Furitsu","year":"1993","unstructured":"Furitsu, T. et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukaemia cell line causing ligand-independent activation of c-kit product. J. Clin. Invest. 92, 1736\u20131744 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnrc1434_CR8","first-page":"1347","volume":"11","author":"HR Glover","year":"1995","unstructured":"Glover, H. R., Baker, D. A., Celetti, A. & Dibb, N. J. Selection of activating mutations of c-fms in FDC-P1 cells. Oncogene 11, 1347\u20131356 (1995).","journal-title":"Oncogene"},{"key":"BFnrc1434_CR9","doi-asserted-by":"crossref","unstructured":"Yeung, Y. -G. & Stanley, E. R. Proteomic approaches to the analysis of early events in colony-stimulating factor-1 signal transduction. Mol. Cell. Proteomics 2, 1143\u20131155.","DOI":"10.1074\/mcp.R300009-MCP200"},{"key":"BFnrc1434_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1615\/CritRevOncog.v5.i2-3.30","volume":"5","author":"S Lev","year":"1994","unstructured":"Lev, S., Blechman, J. M., Givol, D. & Yarden, Y. Steel factor and c-kit protooncogene: genetic lessons in signal transduction. Crit. Rev. Oncog. 5, 141\u2013168 (1994).","journal-title":"Crit. Rev. Oncog."},{"key":"BFnrc1434_CR11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","volume":"79","author":"CH Heldin","year":"1999","unstructured":"Heldin, C. H. & Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283\u20131316 (1999).","journal-title":"Physiol. Rev."},{"key":"BFnrc1434_CR12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","volume":"3","author":"DL Stirewalt","year":"2003","unstructured":"Stirewalt, D. L. & Radich, J. P. The role of FLT3 in haematopoietic malignancies. Nature Rev. Cancer 3, 650\u2013665 (2003).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1434_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","volume":"61","author":"A Ullrich","year":"1990","unstructured":"Ullrich, A. & Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203\u2013212 (1990).","journal-title":"Cell"},{"key":"BFnrc1434_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6","volume":"46","author":"BM Kacinski","year":"1997","unstructured":"Kacinski, B. M. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol. Reprod. Dev. 46, 71\u201374 (1997).","journal-title":"Mol. Reprod. Dev."},{"key":"BFnrc1434_CR15","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","volume":"92","author":"H Nagata","year":"1995","unstructured":"Nagata, H. et al. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl Acad. Sci USA 92, 10560\u201310564 (1995).","journal-title":"Proc. Natl Acad. Sci USA"},{"key":"BFnrc1434_CR16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.0007-1048.2001.03294.x","volume":"116","author":"JT Reilly","year":"2002","unstructured":"Reilly, J. T. Class III receptor tyrosine kinases: role in leukaemogenesis. Br. J. Haematol. 116, 744\u2013757 (2002).","journal-title":"Br. J. Haematol."},{"key":"BFnrc1434_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota, S. et al. Gain of function mutations of c-kit in human gastrointestinal stromal tumours. Science 279, 577\u2013580 (1998).","journal-title":"Science"},{"key":"BFnrc1434_CR18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9440(10)63120-3","volume":"164","author":"K Kemmer","year":"2004","unstructured":"Kemmer, K. et al. KIT mutations are common in testicular seminomas. Am. J. Pathol. 164, 305\u2013313 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1434_CR19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0016-5085(03)01046-1","volume":"125","author":"S Hirota","year":"2003","unstructured":"Hirota, S. et al. Gain-of-function mutations of platelet-derived growth factor receptor \u03b1 gene in gastrointestinal stromal tumours. Gastroenterology 125, 660\u2013667 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrc1434_CR20","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","volume":"299","author":"MC Heinrich","year":"2003","unstructured":"Heinrich, M. C. et al. PDGFRA activating mutations in gastrointestinal stromal tumours. Science 299, 708\u2013710 (2003).","journal-title":"Science"},{"key":"BFnrc1434_CR21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V85.3.790.bloodjournal853790","volume":"85","author":"H Kitayama","year":"1995","unstructured":"Kitayama, H. et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85, 790\u2013798 (1995).","journal-title":"Blood"},{"key":"BFnrc1434_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0092-8674(00)81092-2","volume":"85","author":"LN Johnson","year":"1996","unstructured":"Johnson, L. N., Noble, M. E. M. & Owen, D. J. Active and inactive protein kinases: structural basis for regulation. Cell 85, 149\u2013158 (1996).","journal-title":"Cell"},{"key":"BFnrc1434_CR23","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912\u20131934 (2002).","journal-title":"Science"},{"key":"BFnrc1434_CR24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(02)00741-9","volume":"109","author":"M Huse","year":"2002","unstructured":"Huse, M. & Kuriyan, J. The conformational plasticity of protein kinases. Cell 109, 275\u2013282 (2002).","journal-title":"Cell"},{"key":"BFnrc1434_CR25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.1862342","volume":"253","author":"DR Knighton","year":"1991","unstructured":"Knighton, D. R., et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407\u2013414 (1991).","journal-title":"Science"},{"key":"BFnrc1434_CR26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/372746a0","volume":"372","author":"SR Hubbard","year":"1994","unstructured":"Hubbard, S. R., Ellis, L. & Hendrickson, W. A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746\u2013754 (1994).","journal-title":"Nature"},{"key":"BFnrc1434_CR27","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1093\/emboj\/16.18.5572","volume":"16","author":"SR Hubbard","year":"1997","unstructured":"Hubbard, S. R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16, 5573\u20135581 (1997).","journal-title":"EMBO J."},{"key":"BFnrc1434_CR28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0969-2126(01)00655-4","volume":"9","author":"A Pautsch","year":"2001","unstructured":"Pautsch, A. et al. Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation. Structure 9, 955\u2013965 (2001).","journal-title":"Structure"},{"key":"BFnrc1434_CR29","doi-asserted-by":"crossref","first-page":"38797","DOI":"10.1074\/jbc.M205580200","volume":"277","author":"S Munshi","year":"2001","unstructured":"Munshi, S. et al. Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. J. Biol. Chem. 277, 38797\u201338802 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1434_CR30","doi-asserted-by":"crossref","first-page":"31461","DOI":"10.1074\/jbc.C300186200","volume":"278","author":"CD Mol","year":"2003","unstructured":"Mol, C. D. et al. Structure of a c-Kit product complex reveals the basis for kinase transactivation. J. Biol. Chem. 278, 31461\u201331464 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1434_CR31","doi-asserted-by":"crossref","unstructured":"Mol, C. D. et al. Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase. J. Biol. Chem. 279, 31655\u201331663.","DOI":"10.1074\/jbc.M403319200"},{"key":"BFnrc1434_CR32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/384484a0","volume":"348","author":"H Yamaguchi","year":"1996","unstructured":"Yamaguchi, H. & Hendrickson, W. A. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 348, 484\u2013489 (1996).","journal-title":"Nature"},{"key":"BFnrc1434_CR33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1097-2765(00)80357-3","volume":"3","author":"T Schindler","year":"1999","unstructured":"Schindler, T. et al. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3, 639\u2013648 (1999).","journal-title":"Mol. Cell"},{"key":"BFnrc1434_CR34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nsb870","volume":"9","author":"J Yang","year":"2002","unstructured":"Yang, J. et al. Crystal structure of an activated Akt\/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nature Struct. Biol. 9, 940\u2013944 (2002).","journal-title":"Nature Struct. Biol."},{"key":"BFnrc1434_CR35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S1097-2765(02)00550-6","volume":"9","author":"J Yang","year":"2002","unstructured":"Yang, J. et al. Molecular mechanism for the regulation of protein kinase B\/Akt by hydrophobic motif phosphorylation. Mol. Cell 9, 1227\u20131240 (2002).","journal-title":"Mol. Cell"},{"key":"BFnrc1434_CR36","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1073\/pnas.94.6.2327","volume":"94","author":"Z Wang","year":"1997","unstructured":"Wang, Z., Harkins, P. C., Ulevitch, R. J., Cobb, M. H. & Goldsmith, E. J. The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Proc. Natl Acad. Sci. USA 94, 2327\u20132332 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1434_CR37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0969-2126(99)80173-7","volume":"7","author":"S Bellon","year":"1999","unstructured":"Bellon, S., Fitzgibbon, M. J., Fox, T. & Hsiao, H. M. & Wilson K. P. The structure of phosphorylated p38\u03b3 is monomeric and reveals a conserved activation-loop conformation. Structure Fold Des. 7, 1057\u20131065 (1999).","journal-title":"Structure Fold Des."},{"key":"BFnrc1434_CR38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0092-8674(00)80351-7","volume":"90","author":"BJ Canagarajah","year":"1997","unstructured":"Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H. & Goldsmith, E. J. Activation mechanism of the MAP Kinase ERK2 by dual phosphorylation. Cell 90, 859\u2013869 (1997).","journal-title":"Cell"},{"key":"BFnrc1434_CR39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0163-7258(02)00180-8","volume":"93","author":"RA Engh","year":"2002","unstructured":"Engh, R. A. & Bossenmeyer, D. Structural aspects of protein kinase control \u2014 role of conformational flexibility. Pharmacol. Ther. 93, 99\u2013111 (2002).","journal-title":"Pharmacol. Ther."},{"key":"BFnrc1434_CR40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/363595a0","volume":"363","author":"H De Bondt","year":"1993","unstructured":"De Bondt, H. et al. Crystal structure of cyclin-dependent kinase 2. Nature 363, 595\u2013602 (1993).","journal-title":"Nature"},{"key":"BFnrc1434_CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/376313a0","volume":"376","author":"PD Jeffrey","year":"1995","unstructured":"Jeffrey, P. D. et al. Mechanism of CDK activation revealed by the structure of a cyclin-A CDK2 complex. Nature 376, 313\u2013320 (1995).","journal-title":"Nature"},{"key":"BFnrc1434_CR42","doi-asserted-by":"crossref","first-page":"15625","DOI":"10.1021\/bi0268910","volume":"41","author":"ED Lowe","year":"2002","unstructured":"Lowe, E. D. et al. Specificity determinants of recruitment peptides bound to phospho-CDK2\/cyclin A. Biochemistry 41, 15625\u201315634 (2002).","journal-title":"Biochemistry"},{"key":"BFnrc1434_CR43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"Malumbres, M. & Barbacid, M. To cycle or not to cycle: a critical decision in cancer. Nature Rev. Cancer 1, 222\u2013231 (2001).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1434_CR44","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nsb0896-696","volume":"3","author":"AA Russo","year":"1996","unstructured":"Russo, A. A., Jeffrey, P. D. & Pavletich, N. P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nature Struct. Biol. 3, 696\u2013700 (1996).","journal-title":"Nature Struct. Biol."},{"key":"BFnrc1434_CR45","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","volume":"277","author":"J Stamos","year":"2002","unstructured":"Stamos, J., Sliwkowski, M. X. & Eigenbrot, C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277, 46265\u201346272 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1434_CR46","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","volume":"289","author":"T Schindler","year":"2000","unstructured":"Schindler, T., Bornmann, W., Pellicena, P, Miller, W. T., Clarkson, B. & Kuriyan, J. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289, 1938\u20131942 (2000).","journal-title":"Science"},{"key":"BFnrc1434_CR47","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1074\/jbc.M209861200","volume":"278","author":"FD Bohmer","year":"2003","unstructured":"Bohmer, F. D. et al. A single amino acid exchange inverts susceptibility of related receptor tyrosine kinases for the ATP site inhibitor STI-571. J. Biol. Chem. 278, 5148\u20135155 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1434_CR48","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1093\/emboj\/19.20.5429","volume":"19","author":"BH Zhang","year":"2000","unstructured":"Zhang, B. H. & Guan, K. L. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J. 19, 5429\u20135439 (2000).","journal-title":"EMBO J."},{"key":"BFnrc1434_CR49","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/MCB.23.9.3067-3078.2003","volume":"23","author":"PM Chan","year":"2003","unstructured":"Chan, P. M., Ilangumaran, S., La Rose, J., Chakrabartty, A. & Rottapel, R. Autoinhibition of the Kit receptor tyrosine kinase by the cytosolic juxtamembrane region. Mol. Cell. Biol. 23, 3067\u20133078 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc1434_CR50","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(01)00496-2","volume":"106","author":"L Wybenga-Groot","year":"2001","unstructured":"Wybenga-Groot, L. et al. Structural basis for autoinhibition of the EphB2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 106, 745\u2013757 (2001).","journal-title":"Cell"},{"key":"BFnrc1434_CR51","doi-asserted-by":"crossref","first-page":"26007","DOI":"10.1074\/jbc.M302425200","volume":"278","author":"S Li","year":"2003","unstructured":"Li, S., Covino, N. D., Stein, E. G., Till, J. H. & Hubbard, S. R. Structural and biochemical evidence for an autoinhibitory role for tyrosine 984 in the juxtamembrane region of the insulin receptor. J. Biol. Chem. 278, 26007\u201326014 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1434_CR52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(00)80555-3","volume":"96","author":"M Huse","year":"1999","unstructured":"Huse, M., Chen, Y. -G., Massague, J. & Kuriyan, J. Crystal structure of the cytoplasmic domain of the type I TGF\u03b2 receptor in complex with FKBP12. Cell 96, 425\u2013436 (1999).","journal-title":"Cell"},{"key":"BFnrc1434_CR53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1097-2765(03)00505-7","volume":"13","author":"J Griffith","year":"2004","unstructured":"Griffith, J. et al. The structural basis for autoinhibition of FLT3 by the juxtamembrane domain. Mol. Cell 13, 169\u2013178 (2004).","journal-title":"Mol. Cell"},{"key":"BFnrc1434_CR54","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1038\/sj.onc.1202646","volume":"18","author":"GM Morley","year":"1999","unstructured":"Morley, G. M., Uden, M., Gullick, W. J. & Dibb, N. J. Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation. Oncogene 18, 3076\u20133084 (1999).","journal-title":"Oncogene"},{"key":"BFnrc1434_CR55","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","volume":"99","author":"Y Ma","year":"2002","unstructured":"Ma, Y. et al. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99, 1741\u20131744 (2002).","journal-title":"Blood"},{"key":"BFnrc1434_CR56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","volume":"25","author":"BJ Longley","year":"2001","unstructured":"Longley, B. J., Reguera, M. J. & Ma, Y. Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leuk. Res. 25, 571\u2013576 (2001).","journal-title":"Leuk. Res."},{"key":"BFnrc1434_CR57","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","volume":"22","author":"Y Zermati","year":"2003","unstructured":"Zermati, Y. et al. Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasm. Oncogene 22, 660\u2013664 (2003).","journal-title":"Oncogene"},{"key":"BFnrc1434_CR58","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1074\/jbc.271.7.3347","volume":"271","author":"Y Moriyama","year":"1996","unstructured":"Moriyama, Y. et al. Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase. J. Biol. Chem. 271, 3347\u20133350 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1434_CR59","first-page":"100","volume":"56","author":"E Buchdunger","year":"1996","unstructured":"Buchdunger, E. et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res. 56, 100\u2013104 (1996).","journal-title":"Cancer Res."},{"key":"BFnrc1434_CR60","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR\u2013ABL tyrosine kinase in chronic myeloid leukaemia. N. Engl. J. Med. 344, 1031\u20131037 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc1434_CR61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(02)00899-9","volume":"3","author":"H Joensuu","year":"2002","unstructured":"Joensuu, H. et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 3, 655\u2013664 (2002).","journal-title":"Lancet Oncol."},{"key":"BFnrc1434_CR62","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrc799","volume":"2","author":"T Skorski","year":"2002","unstructured":"Skorski, T. Oncogenic tyrosine kinases and the DNA-damage response. Nature Rev. Cancer 2, 351\u2013360 (2002).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1434_CR63","first-page":"139","volume":"295","author":"E Buchdunger","year":"2000","unstructured":"Buchdunger, E. et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 295, 139\u2013145 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrc1434_CR64","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMoa020150","volume":"347","author":"JF Apperley","year":"2002","unstructured":"Apperley, J. F. et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor \u03b2. N. Engl. J. Med. 347, 481\u2013487 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc1434_CR65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1535-6108(03)00089-8","volume":"3","author":"K Pietras","year":"2003","unstructured":"Pietras, K., Sjoblom, T., Rubin, K., Heldin, C. -H. & Ostman, A. PDGF receptors as cancer drug targets. Cancer Cell 3, 439\u2013443 (2003).","journal-title":"Cancer Cell"},{"key":"BFnrc1434_CR66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","volume":"2","author":"NP Shah","year":"2002","unstructured":"Shah, N. P. et al. Multiple BCR\u2013ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukaemia. Cancer Cell 2, 117\u2013125 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc1434_CR67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1470-2045(03)00979-3","volume":"4","author":"CB Gambacorti-Passerini","year":"2003","unstructured":"Gambacorti-Passerini, C. B. et al. Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias. Lancet Oncol. 4, 75\u201385 (2003).","journal-title":"Lancet Oncol."},{"key":"BFnrc1434_CR68","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0092-8674(03)00196-X","volume":"112","author":"SC Harrison","year":"2003","unstructured":"Harrison, S. C. Variation on an Src-like theme. Cell 112, 737\u2013740 (2003).","journal-title":"Cell"},{"key":"BFnrc1434_CR69","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(03)00190-9","volume":"112","author":"M Azam","year":"2003","unstructured":"Azam, M., Latek, R. R. & Daley, G. Q. Mechanisms of autoinhibition and STI-571\/Imatinib resistance revealed by mutagenesis of BCR\u2013ABL. Cell 112, 831\u2013843 (2003).","journal-title":"Cell"},{"key":"BFnrc1434_CR70","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.1090031","volume":"302","author":"FR Papa","year":"2003","unstructured":"Papa, F. R., Zhang, C., Shokat, K. & Walter, P. Bypassing a kinase activity with an ATP-competitive drug. Science 302, 1533\u20131537 (2003).","journal-title":"Science"},{"key":"BFnrc1434_CR71","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0959-440X(02)00383-4","volume":"12","author":"SR Hubbard","year":"2002","unstructured":"Hubbard, S. R. Protein tyrosine kinases: autoregulation and small-molecule inhibition. Curr. Opin. Struct. Biol. 12, 735\u2013741 (2002).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnrc1434_CR72","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0092-8674(03)00194-6","volume":"112","author":"B Nagar","year":"2003","unstructured":"Nagar, B. et al. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112, 859\u2013871 (2003).","journal-title":"Cell"},{"key":"BFnrc1434_CR73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1535-6108(02)00080-6","volume":"1","author":"CL Sawyers","year":"2002","unstructured":"Sawyers, C. L. Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukaemia. Cancer Cell 1, 413\u2013415 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc1434_CR74","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.193.6.727","volume":"193","author":"EY Lin","year":"2001","unstructured":"Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony stimulating factor 1 promotes progression of mammary tumours to malignancy. J. Exp Med. 193, 727\u2013740 (2001).","journal-title":"J. Exp Med."},{"key":"BFnrc1434_CR75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:CLIN.0000006873.65590.68","volume":"20","author":"LJ Murray","year":"2003","unstructured":"Murray, L. J. et al. SU11248 inhibits tumor growth and CSF-1R dependent osteolysis in an experimental breast cancer bone metastasis model. Clin. Exp. Mestastasis 20, 757\u2013766 (2003).","journal-title":"Clin. Exp. Mestastasis"},{"key":"BFnrc1434_CR76","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1082596","volume":"300","author":"A Bardelli","year":"2003","unstructured":"Bardelli, A. et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949 (2003).","journal-title":"Science"},{"key":"BFnrc1434_CR77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0168-9525(00)02021-7","volume":"16","author":"SC Robertson","year":"2000","unstructured":"Robertson, S. C., Tynan, J. A. & Donoghue, D. J. RTK mutations and human syndromes: when good receptors turn bad. Trends Genet. 16, 265\u2013271 (2000).","journal-title":"Trends Genet."},{"key":"BFnrc1434_CR78","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to Gefitinib. N. Engl. J. Med. 350, 2129\u20132139 (2004)","journal-title":"N. Engl. J. Med."},{"key":"BFnrc1434_CR79","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez, J. G. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497\u20131500 (2004).","journal-title":"Science"},{"key":"BFnrc1434_CR80","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1073\/pnas.2034522100","volume":"100","author":"D Eisenberg","year":"2003","unstructured":"Eisenberg, D. The discovery of the \u03b1-helix and \u03b2-sheet, the principal structural features of proteins. Proc. Natl Acad. Sci. USA 100, 11207\u201311210 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1434_CR81","doi-asserted-by":"crossref","first-page":"13399","DOI":"10.1074\/jbc.274.19.13399","volume":"274","author":"Y Ma","year":"1999","unstructured":"Ma, Y. et al. Inhibition of spontaneous receptor phosphorylation by residues in a putative \u03b1-helix in the KIT intracellular region. J. Biol. Chem. 274, 13399\u201313402 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1434_CR82","first-page":"3329","volume":"9","author":"CR Antonescu","year":"2003","unstructured":"Antonescu, C. R. et al. Association of KIT exon 9 mutations with nongastric primary site and aggressive behaviour: KIT analysis and clinical correlates of 120 gastrointestinal stromal tumours. Clin. Cancer Res. 9, 3329\u20133337 (2003).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc1434_CR83","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0002-9440(10)65250-9","volume":"154","author":"J Lasota","year":"1999","unstructured":"Lasota, J., Jasinski, M., Sarlomo-Rikala, M. & Miettinen, M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumours and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol. 154, 53\u201360 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1434_CR84","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3748\/wjg.v10.i9.1310","volume":"10","author":"YY Hou","year":"2004","unstructured":"Hou, Y. Y. et al. C-kit gene mutation in human gastrointestinal stromal tumours. World J. Gastroenterol. 10, 1310\u20131324 (2004).","journal-title":"World J. Gastroenterol."},{"key":"BFnrc1434_CR85","first-page":"8118","volume":"61","author":"BP Rubin","year":"2001","unstructured":"Rubin, B. P. et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 61, 8118\u20138121 (2001).","journal-title":"Cancer Res."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc1434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1434","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:28:38Z","timestamp":1684456118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc1434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["BFnrc1434"],"URL":"https:\/\/doi.org\/10.1038\/nrc1434","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}